# US 2005/0090644 A1 · Production of secreted polypeptides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0090644 A1
- Document ID: US20050090644A1
- Status: Published application
- Kind: A1
- Application number: 10/636,682
- Filed: 2003-08-06
- Published: 2005-04-28
- Earliest claimed: 1999-12-28
- Assignees: Genencor International, Inc.
- Inventors: Maria Diaz-Torres
- Web page: https://patentgrep.com/patent/US20050090644A1

## CPC

- C12N 9/2417: {from microbiological source}
- C12N 9/54: bacteria being Bacillus
- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12N 15/75: for Bacillus
- C12P 21/02: having a known sequence of two or more amino acids, e.g. glutathione
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}

## Abstract

Described herein are methods and compositions for the production and secretion of polypeptides. Included herein is the use of interrupting peptide transport activity for an increase in polypeptide production and/or secretion.

## Claims

### Claim at position 1

1-28. (canceled)

### Claim 29

A cell comprising a peptide transport operon, wherein said operon has been mutated such that said cell has increased polypeptide secretion.

### Claim 30 (depends on 29)

The cell of claim 29 wherein said operon is a dciA operon.

### Claim 31 (depends on 29)

The cell of claim 29 wherein said operon has been mutated to inactivate a gene product of a dciAE gene or a dciAA gene.

### Claim 32 (depends on 29)

The cell of claim 29 wherein said cell is a gram-positive microorganism.

### Claim 33 (depends on 29)

The cell of claim 29 wherein said cell is a gram-positive microorganism and is a member of the family Bacillus.

### Claim 34 (depends on 29)

The cell of claim 29 wherein said cell is a gram-negative microorganism.

### Claim 35 (depends on 29)

The cell of claim 29 wherein said cell is a gram-negative microorganism and is a member of the family Escherichia.
